AP2000001985A0 - Novel formulation containing paroxetine. - Google Patents

Novel formulation containing paroxetine.

Info

Publication number
AP2000001985A0
AP2000001985A0 APAP/P/2000/001985A AP2000001985A AP2000001985A0 AP 2000001985 A0 AP2000001985 A0 AP 2000001985A0 AP 2000001985 A AP2000001985 A AP 2000001985A AP 2000001985 A0 AP2000001985 A0 AP 2000001985A0
Authority
AP
ARIPO
Prior art keywords
formulation containing
novel formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
APAP/P/2000/001985A
Other languages
English (en)
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AP2000001985A0 publication Critical patent/AP2000001985A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
APAP/P/2000/001985A 1998-05-13 1999-05-13 Novel formulation containing paroxetine. AP2000001985A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
AP2000001985A0 true AP2000001985A0 (en) 2000-12-31

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2000/001985A AP2000001985A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine.

Country Status (20)

Country Link
EP (1) EP1077685A2 (no)
JP (1) JP2002514593A (no)
KR (1) KR20010043545A (no)
CN (1) CN1309557A (no)
AP (1) AP2000001985A0 (no)
AU (1) AU3941099A (no)
BG (1) BG105011A (no)
BR (1) BR9910402A (no)
CA (1) CA2331849A1 (no)
EA (1) EA200001173A1 (no)
GB (1) GB9810180D0 (no)
HU (1) HUP0101931A3 (no)
ID (1) ID27018A (no)
IL (1) IL139596A0 (no)
NO (1) NO20005681L (no)
PL (1) PL344872A1 (no)
SK (1) SK16972000A3 (no)
TR (1) TR200003351T2 (no)
WO (1) WO1999058116A2 (no)
ZA (1) ZA200006465B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4854115B2 (ja) * 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
JP6062422B2 (ja) * 2012-03-29 2017-01-18 杏林製薬株式会社 カプセル製剤
DE102013207447A1 (de) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818990A1 (en) * 1995-04-03 1998-01-21 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
BG105011A (en) 2001-07-31
HUP0101931A2 (hu) 2002-04-29
ID27018A (id) 2001-02-22
JP2002514593A (ja) 2002-05-21
GB9810180D0 (en) 1998-07-08
TR200003351T2 (tr) 2001-03-21
EP1077685A2 (en) 2001-02-28
WO1999058116A3 (en) 2000-02-17
BR9910402A (pt) 2001-01-09
HUP0101931A3 (en) 2002-10-28
NO20005681L (no) 2000-12-01
CN1309557A (zh) 2001-08-22
CA2331849A1 (en) 1999-11-18
ZA200006465B (en) 2001-11-09
IL139596A0 (en) 2002-02-10
WO1999058116A2 (en) 1999-11-18
EA200001173A1 (ru) 2001-04-23
NO20005681D0 (no) 2000-11-10
AU3941099A (en) 1999-11-29
PL344872A1 (en) 2001-11-19
SK16972000A3 (sk) 2001-06-11
KR20010043545A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
AP2000001985A0 (en) Novel formulation containing paroxetine.
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
HUP0104272A3 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
WO2000046210A3 (en) New process for preparing pesticidal intermediates
ZA99477B (en) Process for the preparation of (-)CIS-3-Hydroxy-1-Methyl-4-(2,4,6-Trimethoxyphenyl)Piperidine.
WO1999037291A3 (de) Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe
AP2000002019A0 (en) Novel formulation containing paroxetine.
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
CA2370956A1 (en) Method for causticisation of alkaline solutions
PL356523A1 (en) Substituted 1 and 2 naphthol mannich bases
AU9437698A (en) Compressed chloramine-t tablets and method for the production thereof
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
CA2366600A1 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
HU0201195D0 (no)
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
AU2002223617A1 (en) Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
UA66859C2 (uk) Спосіб стереохімічно контрольованого одержання ізомерно чистих високозаміщених азациклічних сполук
HUP0401989A3 (en) A process for the preparation of the 14 beta-hydroxy-baccatin iii-1,14-carbonate
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana